SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The memecoin CAW (crow with knife) is trending as its community rallies around the project's multi-chain functionality and deflationary tokenomics. Community members emphasize the coin's presence on multiple chains like SOL, CRO, ETH, and BASE, and highlight its strong community.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending as community members rally around the project's real-world applications and brand initiatives, including skateboards, energy drinks and more, with new products and partnerships being actively discussed. The community emphasizes its strong, active, and supportive nature, highlighting the various ways they are building the KENDU brand in real life. Bullish community members are focused on growing the brand and reaching new milestones.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

The crypto, $SLAP, is trending as the community rallies around it, using the term 'slap' to express enthusiasm and action against market downturns. Community members highlight the project's consistency, daily grind, and support from figures like MMA fighter Karolina Arm. Many express bullish sentiment and encourage others to 'slap' the competition and the bears.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending due to positive Phase 1 data for its CTX310 therapy, showing significant cholesterol reduction with a promising safety profile, sparking excitement about its potential. The community is discussing the implications of these results, especially the potential for a blockbuster drug and the validation of CRISPR's in vivo LNP delivery platform. Despite a recent price target reduction from Wedbush, the positive data and insider buying activity fuel optimism about the stock's future.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

NTLA is trending down sharply following news of a clinical hold on its MAGNITUDE trial due to liver toxicity concerns. The community is debating the severity of the issue, potential long-term impacts, and whether the sell-off is an overreaction, while also noting Cathie Wood's recent purchase of a million shares. Discussions include potential merger scenarios and speculation about insider information, alongside lowered price targets from analysts.

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium (CCD) is trending due to its recent partnership with bitcoin.com for age-verified stablecoin payments, sparking community excitement and discussions around its potential. Some view CCD as an undervalued privacy and identity-focused project with strong long-term potential, drawing comparisons to ZEC. The project's focus on compliant, enterprise-ready blockchain solutions and growing institutional interest are also key talking points.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as community members rally behind its grassroots foundation and fair distribution, highlighting its potential as a leading meme coin on the Bitcoin network. Discussion focuses on the growing $DOG treasury and the increasing recognition from major players in the crypto space. Some community members also express excitement about potential exchange listings and increased exposure to retail investors.

Veritone, Inc. engages in the provision of artificial intelligence (AI) computing solutions to media and entertainment, government, and legal and compliance industries. It operates through the following segments: Advertising, aiWARE SaaS Solutions, and aiWARE Content Licensing and Media Services. The Advertising segment places advertisements for clients, primarily with radio broadcasters, podcasters and digital media producers. The aiWARE SaaS Solutions segment offers solutions through a combination of its direct sales force and indirect channel partners, such as value-added resellers (VARs), distributors, system integrators, managed services providers, and referral partners. The aiWARE Content Licensing and Media Services segment sells and markets activities relating to its digital content licensing services business through its direct sales force. The company was founded by Chad Edward Steelberg and Ryan S. Steelberg on June 13, 2014 and is headquartered in Irvine, CA.

Veritone Inc

VERI is trending due to positive analyst coverage and discussions around its growth potential in the AI data refinement sector, particularly with its VDR product. Community members are actively discussing new partnerships with hyperscalers, revenue projections, and the company's strengthened balance sheet following debt reduction. Some are frustrated by recent price action, attributing it to market manipulation and dilution, while others remain bullish, anticipating significant upside and a potential buyout.

Peanut the Squirrel Markets

$PNUT is trending amid community excitement and volatility, with traders actively discussing potential price movements and quick gains. Some users are comparing it to other meme coins like $DOGE and $SHIB, while others are focused on technical analysis and trading strategies to capitalize on short-term pumps. The coin seems to be benefiting from a broader meme coin rally, with community members expressing bullish sentiment and speculating on future price targets.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. is trending amid community discussion around potential new contracts, particularly with TikTok, which could significantly boost revenue. The community is also focused on the company's growing presence in the AI data sector and potential government contracts, fueled by recent executive hires. Some investors believe upcoming earnings will be a catalyst to the stock price rallying significantly.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zimmer Biomet (NYSE:ZBH) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen upgraded shares of Zimmer Biomet from a "hold" rating to a "buy" rating in a research report on Saturday...

UBS Group Issues Pessimistic Forecast for Zimmer Biomet (NYSE:ZBH) Stock Price

UBS Group lowered their price objective on Zimmer Biomet from $96.00 to $88.00 and set a "sell" rating on the stock in a research note on Thursday...

Zimmer Biomet (NYSE:ZBH) Given New $101.00 Price Target at Royal Bank Of Canada

Royal Bank Of Canada reduced their price objective on Zimmer Biomet from $111.00 to $101.00 and set an "outperform" rating for the company in a research report on Thursday...

Sound Shore Management Inc CT Buys 128,772 Shares of Zimmer Biomet Holdings, Inc. $ZBH

Sound Shore Management Inc CT grew its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 16.1% during the second quarter, according to the company in its most recent filing with...

Bryn Mawr Trust Advisors LLC Has $5.77 Million Stock Position in Zimmer Biomet Holdings, Inc. $ZBH

Bryn Mawr Trust Advisors LLC increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 9.0% during the second quarter, according to its most recent Form 13F filing with the SEC...

Bank of New York Mellon Corp Decreases Position in Zimmer Biomet Holdings, Inc. $ZBH

Bank of New York Mellon Corp reduced its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 3.4% during the 2nd quarter, according to the company in its most recent 13F...

Zimmer Biomet (NYSE:ZBH) Announces Earnings Results

Zimmer Biomet (NYSE:ZBH - Get Free Report) announced its earnings results on Wednesday. The medical equipment provider reported $1.90 earnings per share for the quarter, beating the consensus...

Zimmer Biomet (NYSE:ZBH) Hits New 52-Week Low After Analyst Downgrade

Zimmer Biomet (NYSE:ZBH) Reaches New 1-Year Low Following Analyst Downgrade...

Zimmer Biomet (NYSE:ZBH) Given New $112.00 Price Target at BTIG Research

BTIG Research reduced their price objective on shares of Zimmer Biomet from $122.00 to $112.00 and set a "buy" rating for the company in a research note on Wednesday...

Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop

Zimmer Biomet's Q3 EPS beats expectations, but a revenue miss and trimmed outlook send shares sliding in pre-market trading.

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Zimmer Biomet Holdings Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$90.01
Prev Close	$88.51
Open	$89.00
Dividend Yield	0.91%
50-Day Moving Average	$100.15
Beta	0.48
Avg. Volume	1.25M
PE Ratio	21.90

52-Week High	$114.72
52-Week Low	$85.33
Market Capitalization	$17.53B
EPS (Annual)	$4.43
Price to Book	1.38
Revenue Per Employee	$451,682.35
Enterprise Value/EBITDA	N/A

ZBH
Zimmer Biomet Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZBH News

ZBHZimmer Biomet Holdings Inc